Gene: SLC38A9
Official Full Name: solute carrier family 38 member 9provided by HGNC
Gene Summary: Enables several functions, including L-amino acid transmembrane transporter activity; cholesterol binding activity; and guanyl-nucleotide exchange factor activity. Involved in carboxylic acid transport; cellular response to amino acid stimulus; and positive regulation of TORC1 signaling. Located in Ragulator complex; late endosome; and lysosomal membrane. Part of FNIP-folliculin RagC/D GAP. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01490 | Slc38a9 Knockout cell line(C2C12) | Mouse | Slc38a9 | 1:3~1:4 | Negative | Online Inquiry |
SLC38A9 Gene Knockout Cell Lines represent a revolutionary tool in the field of cellular biology, specifically designed to facilitate research on amino acid sensing and intracellular signaling pathways. These genetically modified cell lines have been engineered to silence the SLC38A9 gene, which encodes for a sodium-coupled neutral amino acid transporter that plays a critical role in nutrient sensing, metabolism, and homeostasis within mammalian cells.
The key function of SLC38A9 is its involvement in activating mammalian target of rapamycin (mTOR) pathways in response to amino acid availability. By knocking out this gene, researchers can elucidate the specific contributions of nutrient-sensing pathways to cellular processes, enabling a clearer understanding of metabolic diseases, cancer biology, and the mechanisms underlying protein synthesis regulation. Additionally, these knockout cell lines offer a robust platform for studying the therapeutic effects of potential pharmacological agents targeting the mTOR signaling pathway or other nutrient-sensing mechanisms.
The scientific importance of SLC38A9 Gene Knockout Cell Lines lies in their wide-ranging applications in both fundamental research and clinical settings. These cell lines provide invaluable insights into how disrupted amino acid transport can lead to pathological states, making them a powerful asset to researchers exploring metabolic disorders, neurodegenerative diseases, and even age-related conditions.
When compared to traditional methods like transient transfection or RNA interference, the SLC38A9 knockout approach offers superior stability and specificity of gene targeting. This results in more reliable and reproducible data, essential for advancing scientific understanding and developing new therapies.
Ultimately, these cell lines empower researchers and clinicians alike by providing a sophisticated model for studying nutrient-sensitive pathways, enhancing the precision of their investigations, and supporting innovative therapeutic strategies. Our company’s expertise and commitment to quality ensure that these knockout cell lines are rigorously validated and optimized for experimental use, fostering advancements in the study of cellular metabolism and beyond.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.